|
Market Closed -
Warsaw S.E.
19:57:50 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 210.50 PLN | 0.00% |
|
0.00% | +36.76% |
| 09-03 | Mwb: Bayer Achieving Midterm Targets for Crop Science Division 'Increasingly Credible' | MT |
| 09-03 | US FDA is working with manufacturers to boost estrogen patch supply amid access concerns | RE |
Company Valuation: Bayer AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 46,174 | 47,476 | 33,039 | 18,975 | 36,360 | 47,991 | - | - |
| Change | - | 2.82% | -30.41% | -42.57% | 91.62% | 31.99% | - | - |
| Enterprise Value (EV) 1 | 79,140 | 78,749 | 67,302 | 51,329 | 82,696 | 77,946 | 74,823 | 71,553 |
| Change | - | -0.49% | -14.54% | -23.73% | 61.11% | -5.74% | -4.01% | -4.37% |
| P/E | 46.1x | 11.5x | -11.2x | -7.43x | -10.1x | 22.1x | 15.9x | 13.8x |
| PBR | 1.4x | 1.22x | 1x | 0.59x | 1.4x | 1.7x | 1.55x | 1.41x |
| PEG | - | 0x | 0x | 0.6x | -0.2x | -0x | 0.4x | 0.9x |
| Capitalization / Revenue | 1.05x | 0.94x | 0.69x | 0.41x | 0.8x | 1.05x | 1.02x | 0.99x |
| EV / Revenue | 1.8x | 1.55x | 1.41x | 1.1x | 1.81x | 1.7x | 1.59x | 1.47x |
| EV / EBITDA | 7.08x | 5.83x | 5.75x | 5.07x | 8.55x | 8.04x | 7.26x | 6.46x |
| EV / EBIT | 10.8x | 8.51x | 8.87x | 9.44x | 16.2x | 13.8x | 11.6x | 10.2x |
| EV / FCF | 31.9x | 19x | 28.4x | 11.2x | 24x | -130x | 20.9x | 17.2x |
| FCF Yield | 3.13% | 5.26% | 3.52% | 8.94% | 4.16% | -0.77% | 4.79% | 5.8% |
| Dividend per Share 2 | 2 | 2.4 | 0.11 | 0.11 | 0.11 | 0.16 | 0.558 | 0.9835 |
| Rate of return | 4.26% | 4.97% | 0.33% | 0.57% | 0.3% | 0.33% | 1.14% | 2.01% |
| EPS 2 | 1.02 | 4.22 | -2.99 | -2.6 | -3.68 | 2.206 | 3.072 | 3.544 |
| Distribution rate | 196% | 56.9% | -3.68% | -4.23% | -2.99% | 7.25% | 18.2% | 27.8% |
| Net sales 1 | 44,081 | 50,739 | 47,637 | 46,606 | 45,575 | 45,771 | 47,005 | 48,589 |
| EBITDA 1 | 11,179 | 13,513 | 11,706 | 10,123 | 9,669 | 9,692 | 10,301 | 11,080 |
| EBIT 1 | 7,295 | 9,257 | 7,589 | 5,436 | 5,108 | 5,643 | 6,436 | 7,027 |
| Net income 1 | 1,000 | 4,150 | -2,941 | -2,552 | -3,620 | 2,136 | 2,941 | 3,468 |
| Net Debt 1 | 32,966 | 31,273 | 34,263 | 32,354 | 46,336 | 29,955 | 26,831 | 23,562 |
| Reference price 2 | 47.00 | 48.32 | 33.63 | 19.31 | 37.01 | 48.85 | 48.85 | 48.85 |
| Nbr of stocks (in thousands) | 982,424 | 982,424 | 982,424 | 982,424 | 982,424 | 982,424 | - | - |
| Announcement Date | 01/03/22 | 28/02/23 | 05/03/24 | 04/03/25 | 04/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 32.72x | 11.9x | 24.26x | 0.6% | 1,024B | |
| 30.62x | - | - | 1.95% | 663B | |
| 32.73x | 7.6x | 15.8x | 2.67% | 453B | |
| 19.89x | 4.73x | 11.71x | 2.8% | 352B | |
| 22.72x | 5.84x | 14.51x | 2.7% | 304B | |
| 20.87x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.66x | 7.14x | 13.15x | 2.31% | 236B | |
| 13.33x | 4.82x | 10.06x | 3.78% | 206B | |
| -46.14x | 6.65x | 25.95x | 2.18% | 187B | |
| Average | 17.16x | 6.62x | 15.96x | 2.34% | 408.71B | |
| Weighted average by Cap. | 24.05x | 7.99x | 17.80x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BAYN Stock
- BAY Stock
- Valuation Bayer AG
Select your edition
All financial news and data tailored to specific country editions
